AR116906A1 - Derivados de heteroarilo bicíclico - Google Patents
Derivados de heteroarilo bicíclicoInfo
- Publication number
- AR116906A1 AR116906A1 ARP190103631A ARP190103631A AR116906A1 AR 116906 A1 AR116906 A1 AR 116906A1 AR P190103631 A ARP190103631 A AR P190103631A AR P190103631 A ARP190103631 A AR P190103631A AR 116906 A1 AR116906 A1 AR 116906A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogen
- compounds
- lower alkyl
- bicyclic heteroaryl
- derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente proporciona compuestos heteroarilo bicíclicos que tienen la fórmula general (1), en donde R¹, Ar, n y m son como se describen en el presente documento, composiciones que incluyen los compuestos, procesos de fabricación de los compuestos y métodos de uso de los compuestos. Reivindicación 1: Un compuesto de fórmula (1), donde R¹ es halógeno, alquilo inferior, alquilo inferior sustituido con halógeno, alcoxi inferior o alcoxi inferior sustituido con halógeno, y R¹ puede ser diferente si n = 2 ó 3; m es 1, 2 ó 3; n es 1, 2 ó 3; Ar es un grupo heteroarilo de seis miembros, seleccionado de los compuestos de fórmula (2) y (3), donde R² es hidrógeno, halógeno, alquilo inferior, alquilo inferior sustituido con halógeno o alcoxi inferior; R³ es hidrógeno o halógeno; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212199 | 2018-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116906A1 true AR116906A1 (es) | 2021-06-23 |
Family
ID=64665266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103631A AR116906A1 (es) | 2018-12-13 | 2019-12-12 | Derivados de heteroarilo bicíclico |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20220056036A1 (es) |
| EP (2) | EP3894411B1 (es) |
| JP (1) | JP7566745B2 (es) |
| KR (1) | KR20210102900A (es) |
| CN (2) | CN113179641B (es) |
| AR (1) | AR116906A1 (es) |
| AU (1) | AU2019395774A1 (es) |
| BR (1) | BR112021009443A2 (es) |
| CA (1) | CA3117870A1 (es) |
| CL (1) | CL2021001547A1 (es) |
| CO (1) | CO2021006837A2 (es) |
| CR (1) | CR20210305A (es) |
| DK (1) | DK3894411T3 (es) |
| FI (1) | FI3894411T3 (es) |
| IL (2) | IL283823B2 (es) |
| LT (1) | LT3894411T (es) |
| MA (1) | MA54447A (es) |
| MX (1) | MX2021006761A (es) |
| PE (1) | PE20211776A1 (es) |
| PL (1) | PL3894411T3 (es) |
| PT (1) | PT3894411T (es) |
| RS (1) | RS65821B1 (es) |
| SG (1) | SG11202103340PA (es) |
| TW (1) | TWI831892B (es) |
| WO (1) | WO2020120521A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8703763B2 (en) * | 2011-03-02 | 2014-04-22 | Hoffmann-La Roche Inc. | Bridged piperidine derivatives |
| WO2017042114A1 (en) | 2015-09-09 | 2017-03-16 | F. Hoffmann-La Roche Ag | Bridged piperidine derivatives |
| CN108137579B (zh) * | 2015-12-10 | 2022-01-07 | 豪夫迈·罗氏有限公司 | 桥连哌啶衍生物 |
| WO2018001918A1 (en) * | 2016-06-27 | 2018-01-04 | F. Hoffmann-La Roche Ag | Triazolopyridines as gamma-secretase modulators |
| WO2018083050A1 (en) * | 2016-11-01 | 2018-05-11 | F. Hoffmann-La Roche Ag | Bicyclic heteroaryl derivatives |
| CN109790149B (zh) | 2016-11-08 | 2022-05-17 | 豪夫迈·罗氏有限公司 | 苯氧基三唑类化合物 |
| RU2757276C2 (ru) | 2016-12-16 | 2021-10-12 | Пайплайн Терапьютикс, Инк. | Способы лечения кохлеарной синаптопатии |
| US11370802B2 (en) | 2018-01-22 | 2022-06-28 | Hoffmann-La Roche, Inc. | Triazolo-azepine derivatives |
-
2019
- 2019-12-11 KR KR1020217017774A patent/KR20210102900A/ko unknown
- 2019-12-11 JP JP2021533563A patent/JP7566745B2/ja active Active
- 2019-12-11 AU AU2019395774A patent/AU2019395774A1/en active Pending
- 2019-12-11 MX MX2021006761A patent/MX2021006761A/es unknown
- 2019-12-11 SG SG11202103340PA patent/SG11202103340PA/en unknown
- 2019-12-11 PE PE2021000726A patent/PE20211776A1/es unknown
- 2019-12-11 PL PL19824250.5T patent/PL3894411T3/pl unknown
- 2019-12-11 EP EP19824250.5A patent/EP3894411B1/en active Active
- 2019-12-11 PT PT198242505T patent/PT3894411T/pt unknown
- 2019-12-11 DK DK19824250.5T patent/DK3894411T3/da active
- 2019-12-11 CN CN201980076253.8A patent/CN113179641B/zh active Active
- 2019-12-11 CN CN202311792520.6A patent/CN117946116A/zh active Pending
- 2019-12-11 US US17/413,413 patent/US20220056036A1/en active Pending
- 2019-12-11 CA CA3117870A patent/CA3117870A1/en active Pending
- 2019-12-11 IL IL283823A patent/IL283823B2/en unknown
- 2019-12-11 EP EP24177200.3A patent/EP4424370A2/en active Pending
- 2019-12-11 CR CR20210305A patent/CR20210305A/es unknown
- 2019-12-11 LT LTEPPCT/EP2019/084538T patent/LT3894411T/lt unknown
- 2019-12-11 MA MA054447A patent/MA54447A/fr unknown
- 2019-12-11 RS RS20240883A patent/RS65821B1/sr unknown
- 2019-12-11 WO PCT/EP2019/084538 patent/WO2020120521A1/en active Application Filing
- 2019-12-11 FI FIEP19824250.5T patent/FI3894411T3/fi active
- 2019-12-11 IL IL310081A patent/IL310081A/en unknown
- 2019-12-11 BR BR112021009443-1A patent/BR112021009443A2/pt unknown
- 2019-12-12 AR ARP190103631A patent/AR116906A1/es unknown
- 2019-12-12 TW TW108145480A patent/TWI831892B/zh active
-
2021
- 2021-05-24 CO CONC2021/0006837A patent/CO2021006837A2/es unknown
- 2021-06-11 CL CL2021001547A patent/CL2021001547A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL283823B2 (en) | 2024-07-01 |
| EP4424370A2 (en) | 2024-09-04 |
| CL2021001547A1 (es) | 2021-12-24 |
| BR112021009443A2 (pt) | 2021-08-17 |
| IL310081A (en) | 2024-03-01 |
| EP3894411A1 (en) | 2021-10-20 |
| TW202039499A (zh) | 2020-11-01 |
| TWI831892B (zh) | 2024-02-11 |
| RS65821B1 (sr) | 2024-09-30 |
| PT3894411T (pt) | 2024-08-08 |
| IL283823A (en) | 2021-07-29 |
| SG11202103340PA (en) | 2021-04-29 |
| MA54447A (fr) | 2022-03-23 |
| IL283823B1 (en) | 2024-03-01 |
| CN113179641A (zh) | 2021-07-27 |
| FI3894411T3 (fi) | 2024-08-15 |
| CA3117870A1 (en) | 2020-06-18 |
| LT3894411T (lt) | 2024-08-26 |
| US20220056036A1 (en) | 2022-02-24 |
| CN117946116A (zh) | 2024-04-30 |
| JP2022513466A (ja) | 2022-02-08 |
| CO2021006837A2 (es) | 2021-06-10 |
| MX2021006761A (es) | 2021-07-15 |
| CR20210305A (es) | 2021-07-20 |
| DK3894411T3 (da) | 2024-08-19 |
| EP3894411B1 (en) | 2024-06-19 |
| JP7566745B2 (ja) | 2024-10-15 |
| PE20211776A1 (es) | 2021-09-08 |
| CN113179641B (zh) | 2024-01-02 |
| PL3894411T3 (pl) | 2024-10-07 |
| KR20210102900A (ko) | 2021-08-20 |
| AU2019395774A1 (en) | 2021-04-08 |
| WO2020120521A1 (en) | 2020-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY38297A (es) | Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos | |
| PE20221336A1 (es) | Compuestos triciclicos sustituidos | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| EA201690019A1 (ru) | Производное аминотриазина и содержащая его фармацевтическая композиция | |
| AR112834A1 (es) | Derivados de rapamicina | |
| AR110405A1 (es) | Compuestos | |
| AR109709A1 (es) | Inhibidores de la fosfatidilinositol 3-quinasa | |
| SA515361086B1 (ar) | Fasn مركبات وتركيبات جديدة لتثبيط | |
| AR099498A1 (es) | Compuestos de triazina y su uso farmacéutico | |
| AR112338A2 (es) | Arilciclohexiléteres de dihidro-tetraazabenzoazuleno | |
| PE20161405A1 (es) | Analogos de cortistatina y sintesis y usos de los mismos | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| AR119943A1 (es) | Compuestos heterocíclicos | |
| PE20181304A1 (es) | Derivados de indol n-sustituidos como moduladores de los receptores de pge2 | |
| EA202092921A1 (ru) | Полициклическое производное карбамоилпиридона | |
| EA201600403A1 (ru) | N-ацилиминогетероциклические соединения | |
| ES2567311T3 (es) | 6-(3-Aza-biciclo[3.1.0]hex-3-il)-2-fenil-pirimidinas como antagonistas del receptor de ADP | |
| CO6190626A2 (es) | Compuestos y composiciones como inhibidores de proteasa activadora de canal | |
| AR110282A1 (es) | Compuestos de amida bicíclica y uso de éstos en el tratamiento de enfermedades mediadas por rip1 | |
| CR20230115A (es) | Compuestos heterocíclicos | |
| AR102258A1 (es) | Compuestos de quinolina y quinazolina | |
| ES2568909T3 (es) | Novedosos compuestos antagonistas del receptor de la neuroquinina 1 | |
| AR077301A1 (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano como antagonistas de 5-ht1a y 5-ht1b | |
| CO2022004391A2 (es) | Derivados de 5-oxa-2–azaespiro[3.4]octano como agonistas de m4 | |
| AR091520A1 (es) | Inhibidores piranopiridona de tanquirasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |